Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Watson Pharmaceuticals Receives FDA Approval For Fruit And Cinnamon Flavored Coated Nicotine Gums
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration to market its over-the-counter Nicotine Polacrilex Gum USP, 2 mg and 4 mg strengths in the coated fruit and cinnamon flavors.

Siemens Enterprise Communications To Provide Multi-million Pound Secure LAN For Barts And The London NHS Trust Hospitals
Siemens Enterprise Communications has won a four year multi-million pound framework contract to provide Barts and The London NHS Trust with an integrated Enterasys fixed and wireless LAN and security infrastructure. The first phase in a three stage communications programme, the new infrastructure - due for completion in 2010 - will provide a single network able to handle all optical images, video streaming and traffic from multiple wireless devices and PCs for 300 beds at Barts hospital.
News of the day
Brain Irradiation In Lung Cancer
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
Medical Devices

Retinopathy Of Prematurity Diagnosis Time Significantly Reduced Using Telemedicine

To be properly diagnosed, retinopathy of prematurity (ROP), the leading cause of childhood blindness in the United States and worldwide, requires a time intensive process and significant coordination between ophthalmologist and NICU staff. A recent study examining ROP diagnosis speed using indirect ophthalmoscopy versus telemedicine, remote medical consultation, is featured in the July issue of the American Journal of Ophthalmology, published by Elsevier. The study was designed to compare the ophthalmologist"s speed of ROP diagnosis using telemedicine versus traditional bedside ophthalmoscopy. The findings reveal that: 1) ROP diagnosis by the ophthalmologist is significantly faster via telemedicine, and 2) there are significant time requirements by ophthalmologists associated with ROP diagnosis at the NICU bedside beyond ophthalmoscopy. In particular, additional time is taken for travel and communication with families and hospital staff. To counteract these time requirements the implementation of telemedicine for ROP management has the ability to decrease the time commitment for examining ophthalmologists. Previous studies have shown that telemedical ROP diagnosis is highly accurate and reliable compared with ophthalmoscopy, and future work is required to address workflow questions in more detail. According to senior author Michael F. Chiang, MD, "Telemedicine has potential to improve the delivery and accessibility of care for infants with ROP by reducing geographical and logistical barriers. This study shows that it may also improve the efficiency of care for ophthalmologists." Given the increased number of at-risk infants in the United States and worldwide, improved use of ophthalmology res may help to prevent cases of avoidable childhood blindness. The article is "The Speed of Telemedicine vs Ophthalmoscopy for Retinopathy of Prematurity Diagnosis" by Grace M. Richter, Grace Sun, Thoms C. Lee, R.V. Chuan, John L. Flynn, Justin Starren, and Michael Chiang. Maureen Hunter Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009